作者
Erin P Price, Meagan L Seymour, Derek S Sarovich, Jennie Latham, Spenser R Wolken, Joanne Mason, Gemma Vincent, Kevin P Drees, Stephen M Beckstrom-Sternberg, Adam M Phillippy, Sergey Koren, Richard T Okinaka, Wai-Kwan Chung, James M Schupp, David M Wagner, Richard Vipond, Jeffrey T Foster, Nicholas H Bergman, James Burans, Talima Pearson, Tim Brooks, Paul Keim
发表日期
2012/8
期刊
Emerging infectious diseases
卷号
18
期号
8
页码范围
1307
出版商
Centers for Disease Control and Prevention
简介
In December 2009, two cases of injectional anthrax were diagnosed in heroin users in Scotland after B. anthracis was detected in blood cultures (8). These cases marked the beginning of an emerging anthrax outbreak among European heroin users. Over the following months, 14 anthrax deaths were confirmed and 119 anthrax cases were suspected (9), leading to increasing media attention as the severity of this outbreak became more apparent. This attention was spurred by 3 factors. First, B. anthracis is not found naturally in Scotland, and human cases of anthrax in Europe are extremely rare, with only 3 cases of anthrax notified in Europe in 2008 (10). Second, the pathology of injectional anthrax is especially devastating (11, 12). Third, anthrax cases appeared to befall only an ostensibly targeted population of persons, leading to initial suggestions of deliberate contamination of the heroin supply. Although …
学术搜索中的文章
EP Price, ML Seymour, DS Sarovich, J Latham… - Emerging infectious diseases, 2012